StonvexLoading…
StonvexCore line items from IBEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $558.27M | $508.57M | $523.12M | $131.56M |
Operating Income | $46.61M | $39.43M | $40.48M | $13.05M |
Net Income | $36.86M | $33.66M | $31.58M | $11.28M |
EPS (Diluted) | $2.36 | $1.84 | $1.67 | $0.60 |
Total Assets | $273.21M | $293.90M | $293.32M | Not available |
Total Liabilities | $138.91M | $128.10M | $143.36M | Not available |
Cash & Equivalents | $15.35M | $62.72M | $57.43M | Not available |
Free Cash Flow OCF − CapEx | $27.29M | $27.05M | $22.91M | Not available |
Shares Outstanding | 13.36M | 17.02M | 18.28M | Not available |